Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
  1. Home
  3. Long Non-coding Rna Snhg3 Promotes The Progression Of Cholangiocarcinoma By Regulating The Mir-151a-3p/stat5a Axis.
  1. Home
  3. Long Non-coding Rna Snhg3 Promotes The Progression Of Cholangiocarcinoma By Regulating The Mir-151a-3p/stat5a Axis.

Related Experiment Video

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

353

Long Non-Coding RNA SNHG3 Promotes the Progression of Cholangiocarcinoma by Regulating the miR-151a-3p/STAT5a Axis.

Xiaoping Wei1, Dongyun Cun1, Danping Yang1

  • 1Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
|December 6, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Long non-coding RNA SNHG3 promotes cholangiocarcinoma (CCA) progression by targeting miR-151a-3p and activating the STAT5a axis. This finding offers new therapeutic strategies for CCA treatment.

Keywords:
SNHG3STAT5acholangiocarcinomamiR-151a-3p

More Related Videos

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.4K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.5K

Related Experiment Videos

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

353
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.4K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.5K

Area of Science:

  • Oncology
  • Molecular Biology
  • RNA Biology

Background:

  • Long non-coding RNAs (lncRNAs) play a role in malignant tumor development, including cholangiocarcinoma (CCA).
  • The specific mechanisms of lncRNA SNHG3 in CCA progression are not fully understood.

Purpose of the Study:

  • To investigate the role of SNHG3 in CCA development.
  • To elucidate the molecular mechanisms underlying SNHG3's function in CCA.

Main Methods:

  • Cell viability, apoptosis, migration, and invasion assays (CCK-8, TUNEL, wound healing, Transwell).
  • Dual-luciferase reporter and RNA pull-down assays to confirm molecular interactions.
  • Gene knockdown experiments (SNHG3, STAT5a, miR-151a-3p inhibitor).

Main Results:

  • SNHG3 and STAT5a were upregulated, while miR-151a-3p was downregulated in CCA tissues and cells.
  • SNHG3 knockdown inhibited CCA cell proliferation, apoptosis, migration, and invasion.
  • SNHG3 directly targets miR-151a-3p, and this interaction promotes CCA progression.
  • STAT5a knockdown counteracted the effects of SNHG3 and miR-151a-3p manipulation.

Conclusions:

  • SNHG3 promotes CCA progression through the miR-151a-3p/STAT5a pathway.
  • This study provides novel insights for potential clinical treatments of CCA.